LHC Group, Inc
Healthcare · Services-Home Health Care Services · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $2.28B | $2.22B | $2.06B | $2.08B | $1.81B | $1.06B |
| Operating income | $108.5M | $185.6M | $178.1M | $151.6M | $111.0M | $74.7M |
| Net income | $60.2M | $143.6M | $137.9M | $113.9M | $78.9M | $60.4M |
| Total assets | $2.90B | $2.90B | $2.48B | $2.14B | $1.93B | $793.7M |
| Total liabilities | $1.19B | $1.23B | $851.1M | $617.9M | $489.6M | $273.7M |
| Equity | $1.60B | $1.57B | $1.53B | $1.41B | $1.32B | $448.9M |
| EPS (diluted) | $1.30 | $3.69 | $3.56 | $3.07 | $2.29 | $2.79 |
| Shares out. | 31.7M | 31.6M | 31.5M | 31.4M | 18.3M | 18.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- 4.8%
- Net margin
- 2.6%
- Return on equity
- 3.8%
- Return on assets
- 2.1%
- Return on capital (ROCE)
- 4.2%
- Liabilities / assets
- 41.1%
- Debt / equity
- 0.75×
- Book value / share
- $50.36
- Revenue growth (YoY)
- 2.8%
- Net income growth (YoY)
- −58.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 2.81safe
- Accruals / assets
- 0.4%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Turner BrentDirector | Feb 22, 2023 | D | 14,200 | $170.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 22, 2023
- Delisting / listing-standard noticeJan 12, 2023
- Other material eventDec 7, 2022
- Results of operations · Regulation FD disclosureNov 2, 2022
- Results of operations · Regulation FD disclosureAug 3, 2022
- Shareholder voteJun 21, 2022
- Other material eventJun 14, 2022
- Other material eventJun 10, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.